Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Predictive Oncology Inc
POAICurrent price
0.83 USD
+0.048 USD (+6.15%)
Last closed
0.77 USD
Company
www.predictive-oncology.com
ISIN
US74039M2008
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Capitalization
4 601 715 USD
Yield for 12 month
-74.52 %
1Y
3Y
5Y
10Y
15Y
POAI
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania. Address: 91 43rd Street, Pittsburgh, PA, United States, 15201
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
+1 780 093 USD
Last Year
+1 505 459 USD
Current Quarter
+278 722 USD
Last Quarter
+419 646 USD
Current Year
+433 407 USD
Last Year
+1 000 352 USD
Current Quarter
-38 411 USD
Last Quarter
+69 666 USD
Key Figures POAI
1 year
3 years
5 years
10 years
EBITDA
-13 437 984 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-55.8 %
PEG Ratio
–
Return On Equity TTM
-149.36 %
Wall Street Target Price
3 USD
Revenue TTM
1 748 456 USD
Book Value
0.72 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-43.1 %
Dividend Yield
–
Gross Profit TTM
1 000 352 USD
Earnings per share
-3.34 USD
Diluted Eps TTM
-3.34 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics POAI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History POAI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
24.04.2023
Dividend Date
29.10.2019
Stock Valuation POAI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.1269
Price Sales TTM
2.6319
Enterprise Value EBITDA
-0.5121
Price Book MRQ
1.1242
Financials POAI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators POAI
For 52 weeks
0.55 USD
3.76 USD
50 Day MA
0.79 USD
Shares Short Prior Month
102 912
200 Day MA
1.61 USD
Short Ratio
1.79
Shares Short
161 249
Short Percent
2.45 %
BeatStart